HPQ
63
6
RIG
60
2
MLM
57
6
PM
62
-2
CINF
53
2
DD
63
3
ADSK
70
2
HCA
44
-2
PSA
58
2
CVX
47
3
HD
57
2
LEG
36
4
TRIP
47
3
LLY
37
-3
FDX
43
3
PG
56
5
SLB
55
2
MTB
67
2
FLR
58
3
NAVI
52
5
HPQ
63
6
RIG
60
2
MLM
57
6
PM
62
-2
CINF
53
2
DD
63
3
ADSK
70
2
HCA
44
-2
PSA
58
2
CVX
47
3
HD
57
2
LEG
36
4
TRIP
47
3
LLY
37
-3
FDX
43
3
PG
56
5
SLB
55
2
MTB
67
2
FLR
58
3
NAVI
52
5
Financhill
Back

Titan Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison

Sell
24

TTNP
Titan Pharmaceuticals

Last Price:
3.63
Seasonality Move:
12.1%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
24
Titan Pharmaceuticals (TTNP) is a Sell

Is Titan Pharmaceuticals a Buy, Sell or Hold?

  • The current Titan Pharmaceuticals [TTNP] share price is $3.71. The Score for TTNP is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • TTNP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TTNP Stock Price Chart

What is Titan Pharmaceuticals's stock price today?

  • The Titan Pharmaceuticals share price today is $3.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TTNP is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TTNP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 37.46 Sell
Chaikin Money Flow: -3175 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.79 - 4.27) Sell
Bollinger Bands (100): (4.24 - 6.2) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

TTNP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.83 Sell
20-day SMA: 3.98 Sell
50-day SMA: 4.61 Sell
200-day SMA: 6.09 Sell
8-day EMA: 3.84 Sell
20-day EMA: 4.03 Sell
50-day EMA: 4.53 Sell
200-day EMA: 6.12 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Titan Pharmaceuticals Earnings Growth & TTNP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Titan Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):